<p>Here’s why activist billionaire investor Carl Icahn is telling Cigna shareholders to vote against its purchase of Express Scripts. Also, what Regeneron Pharmaceuticals and bluebird bio's new deal means for investors.</p>

Here’s why activist billionaire investor Carl Icahn is telling Cigna shareholders to vote against its purchase of Express Scripts. Also, what Regeneron Pharmaceuticals and bluebird bio's new deal means for investors.

<p>Here’s why activist billionaire investor Carl Icahn is telling Cigna shareholders to vote against its purchase of Express Scripts. Also, what&nbsp;Regeneron Pharmaceuticals and bluebird bio's&nbsp;new deal means for&nbsp;investors.</p>

Healthcare: Carl Icahn Fires a Shot at Cigna and Express Scripts’ Planned Tie-Up

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.

Share Healthcare: Carl Icahn Fires a Shot at Cigna and Express Scripts’ Planned Tie-Up

Sign up to save your podcasts

Healthcare: Carl Icahn Fires a Shot at Cigna and Express Scripts’ Planned Tie-Up

Healthcare: Carl Icahn Fires a Shot at Cigna and Express Scripts’ Planned Tie-Up

More shows like Industry Focus

Motley Fool Money

Motley Fool Answers

Rule Breaker Investing

MarketFoolery